Recent News in Healthcare
Recent News by GLG Leaders
What is a GLG Leader?
What is a GLG Leader?
July 18, 2008Will prescription drug spending decreases affect dermatology?
Analysis of: Patients Curb Prescription Spending | online.wsj.com
Author: Sunil Dhawan, Clinical Assistant Professor of Dermatology, Stanford University
This article is important in that it describes a worrying trend for branded pharmaceutical companies. As copays for branded products go up and the patients economic status worsens, the use of these drugs will fall. This may be especially true for medications in dermatology, where the perceived need may be less than that for a cardiac drug. The pipelines in dermatology are smaller due to high...
July 17, 2008
A Complex Personal and Societal Issue
Analysis of: Costly Cancer Drug Offers Hope, but Also a Dilemma | www.nytimes.com
Author: Evan Siegel, President and Chief Executive Officer, Ground Zero Pharmaceuticals, Inc.
A Complex Personal and Societal Issue
Analysis of: Costly Cancer Drug Offers Hope, but Also a Dilemma | www.nytimes.com
Author: Evan Siegel, President and Chief Executive Officer, Ground Zero Pharmaceuticals, Inc.
The issues associated with expensive therapeutics are multifaceted and involve personal, professional and societal components. Value related to medical treatment is uniquely assessed by each individual with respect to his/her financial burden, overall lifestyle and quality of life, societal role, and belief structure. Society itself is beset with contrary stakeholders in the insurance, governmental,...
July 17, 2008
The New PhRMA “Code on Interactions with Health Care Professionals”: What will it mean?
Analysis of: PhRMA “Code on Interactions with Health Care Professionals” | www.thepinksheet.com
Author: Joseph Bertino, Independent Consultant, Bertino Consulting
The New PhRMA “Code on Interactions with Health Care Professionals”: What will it mean?
Analysis of: PhRMA “Code on Interactions with Health Care Professionals” | www.thepinksheet.com
Author: Joseph Bertino, Independent Consultant, Bertino Consulting
-The new code will limit all gifts and meals to healthcare professionals, thus reducing pharmaceutical representative contact time. -Medical education programs will follow guidelines established by professional education groups -The guidelines do not go far enough for sales representative-healthcare professional interactions
July 15, 2008Infectious Diseases
Analysis of: BD Diagnostics' GeneOhm Cdiff test receives CE mark for rapid diagnosis of Clostridium difficile infection | www.labnews.com
Author: Ken Powell, President, Genesis Business Development
BD GeneOhm's recent CE Mark for its molecular diagnostic test for the rapid diagnosis of Clostridium difficile infection will likely intensify the competition between BD and Cepheid. Both companies market tests for the $1 billion dollar Methicillin-Resistant Staphylococcus Aureus (MRSA) market.
July 15, 2008Novel Test for Appendicitis
Analysis of: AspenBio Pharma Commences FDA Clinical Trial for AppyScore(TM) Appendicitis Blood Test | www.medcompare.com
Author: Ken Powell, President, Genesis Business Development
A new test form AspenBio could revolutionalize the diagnosis of appendicitis. Over 6 million patients present to Emergency Departments each year with abdominal pain, resulting in approximately 700,000 appendectomies. Over $5 billion is spent each year in the US on CT scans, the currently available diagnostic method for appendicitis.
All Recent Analyses
Request a free trial
July 18, 2008
Possible Impact Of Recently Reported Fractures On The Use Of Alendronate
Analysis of: Drugs to Build Bones May Weaken Them | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: Drugs to Build Bones May Weaken Them | www.nytimes.com
Author: GLG Expert Contributor
1. This study may not have a big impact on the prescriptions of alendronate in the short term unless this problem is found to be more wide-spread. With the increased incidence of jaw necrosis reported earlier, physicians will carefully weigh the benefits before starting alendronate. 2. The fractures were found to be in patients who had taken alendronate for an average of 6.9 years. Physicians may...
July 18, 2008
Fractures from Fosamax???
Analysis of: Drugs to Build Bones May Weaken Them | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: Drugs to Build Bones May Weaken Them | www.nytimes.com
Author: GLG Expert Contributor
Patients may ask about this. Haven't heard anyone yet.
July 18, 2008
Intermittent Use of Topical Tacrolimus in Stable Atopic Dermatitis
Analysis of: Intermittent tacrolimus Ointment therapy Helps Prevent Relapse Of Stabilized Atpoic Dermatitis | www.medscape.com
Author: GLG Expert Contributor
Analysis of: Intermittent tacrolimus Ointment therapy Helps Prevent Relapse Of Stabilized Atpoic Dermatitis | www.medscape.com
Author: GLG Expert Contributor
Tacrolimus is used either alone or with topical steroids in acute stages while tacrolimus alone is preferred for maintenance so as to reduce the side effects of steroids. Relapses are a rule rather than exception in atopic dermatitis. Use of moisturizing cleansers, emollients and avoidance of irritants like woolen fibres are very important yet flares do occur. The study proposes a regular thrice weekly...
July 18, 2008
Getting Even Less than What We're Paying for in Healthcare
Analysis of: While the U.S. Spends Heavily on Health Care, a Study Faults the Quality | www.nytimes.com
Author: GLG Expert Contributor
Analysis of: While the U.S. Spends Heavily on Health Care, a Study Faults the Quality | www.nytimes.com
Author: GLG Expert Contributor
The second national scorecard shows that the U.S. spends more than twice as much on each person as most other industrialized countries. But it has fallen to last place (out of 19) among major industrialized nations in preventing deaths through the use of timely and effective care, according to a report just released by the Commonwealth Fund, a nonprofit research group in New York.
July 18, 2008
Less Prescription Use May Lead to More Health-Care Expenses
Analysis of: Patients Curb Prescription Spending | online.wsj.com
Author: GLG Expert Contributor
Analysis of: Patients Curb Prescription Spending | online.wsj.com
Author: GLG Expert Contributor
Prescription drugs provide the greatest cost-to-benefit ratio in health-care. Decreased prescription drug use likely will lead to increasing severity of health problems. This may lead to increased sales opportunities for helotage related companies but have serious consequences for tax supported health-care systems.
View More
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
Higher food prices are here to stay
www.guardian.co.uk
Glaxo Seeks Guidance From Health Systems
online.wsj.com
8-Year-Olds on Statins? A New Plan Quickly Bites Back
www.nytimes.com
Bill to Block Medicare-Fee Cuts
online.wsj.com
Costly Cancer Drug Offers Hope, but Also a Dilemma
www.nytimes.com
The folly of biofuels
July 15, 2008
Notice the US is not part of the discussion?
July 14, 2008
Medicare fee cuts: Saved by someone who may appreciate the significance........
July 10, 2008
What ever happens I can assure you the Doctors will be f........
July 8, 2008
Complicated issue
July 7, 2008

